Skip to main content
MEDICA GROUP PLC logo

MEDICA GROUP PLC — Investor Relations & Filings

Ticker · MGPM ISIN · GB00BYV24996 LEI · 213800B8XE5FUSZF5Z16 IL Human health and social work activities
Open in API
Filings indexed 360 across all filing types
Latest filing 2023-05-17 Major Shareholding Noti…
Country GB United Kingdom
Listing IL MGPM

About MEDICA GROUP PLC

https://medica.co.uk/

Medica Group PLC is a provider of telemedicine services, specializing in teleradiology and telepathology. The company partners with healthcare organizations, including NHS Trusts and independent sector providers, to deliver outsourced interpretation and reporting of diagnostic imaging and pathology samples. Leveraging a global network of specialist radiologists and pathologists, Medica provides fast, quality-assured reporting services designed to shorten patient wait times and enhance clinical workflows. Its offerings cover a wide range of needs, from routine elective procedures to urgent and specialized areas such as stroke, major trauma, musculoskeletal (MSK), and PET-CT imaging.

Recent filings

Filing Released Lang Actions
Form 8.3 - Medica Group plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form relates to disclosures required during a takeover or merger situation concerning interests in securities. This specific type of filing, dealing with insider/significant shareholder activity during a takeover process, does not fit neatly into the standard categories like 10-K, ER, or IR. It is a specific regulatory disclosure related to corporate actions, but not M&A activity (TAR) itself, nor a general director's dealing (DIRS). Given the options, the most appropriate classification for a specific regulatory disclosure that doesn't match the primary financial reports or common corporate actions is the general 'Regulatory Filings' fallback category (RNS), as it is a mandatory filing under the Takeover Code.
2023-05-17 English
Form 8.3 - Medica Group plc
M&A Activity Classification · 98% confidence The document is explicitly titled 'FORM 8.3 - Medica Group plc' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of filing relates to insider dealing or significant ownership changes during a takeover/merger event. Among the provided codes, 'TAR' (M&A Activity) is the most appropriate category as it covers takeover bids and related disclosures, even though the specific form (Form 8.3) is a dealing disclosure related to the M&A event. It is not a general Director's Dealing (DIRS) because it is specifically mandated by the Takeover Code in the context of an offer.
2023-05-16 English
Form 8.3 - Medica Group plc
Major Shareholding Notification Classification · 97% confidence The document is explicitly titled "FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is used to disclose interests and dealings in the securities of an offeror or offeree during a takeover situation. This specific disclosure relates to an interest in 'Medica Group plc' during a potential offer. While this is a regulatory filing related to a takeover, the closest specific category that covers insider/significant shareholder dealings related to corporate actions (like takeovers) is 'Director's Dealing' (DIRS), although this form is broader than just directors. However, given the context of mandatory disclosure related to a takeover bid (Rule 8.3), it is a highly specific regulatory disclosure. Since there is no specific 'Takeover Disclosure' code, and it involves reporting personal/entity dealings in securities during a corporate event, it aligns most closely with 'Director's Dealing' (DIRS) or potentially 'Regulatory Filings' (RNS) as a fallback. Since it is a mandatory disclosure under the Takeover Code regarding interests/dealings, and DIRS covers insider trades, I will classify it as DIRS, as it is a specific type of dealing disclosure, even if not strictly a director. If DIRS is too narrow, RNS is the fallback. Given the structure and content (dealing disclosure), DIRS is the most appropriate specific fit among the options provided for reporting security interests/transactions by an interested party.
2023-05-15 English
Form 8.3 - Medica Group plc
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'FORM 8.3 - PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code (the “Code”)'. This form is used to disclose interests and dealings in the securities of an offeror or offeree during a takeover situation. This specific disclosure relates to Medica Group plc, indicating activity under the UK Takeover Code. This type of filing, which reports insider/significant shareholder dealings related to a takeover, is most closely aligned with insider trading/director dealing disclosures, but the context is specifically about a takeover bid. Among the provided codes, 'Director's Dealing (DIRS)' is the closest fit for reporting personal share transactions by insiders/significant holders, although this is specifically mandated by the Takeover Code (Rule 8.3). Since there is no specific code for 'Takeover Disclosure Form 8.3', and it involves reporting interests/dealings by a major holder (Millennium International Management LP) in relation to an offer, it falls under the broader category of insider/significant shareholder transaction reporting. Given the options, DIRS (Director's Dealing) is the most appropriate category for reporting significant security interests/dealings by an involved party, even if the context is a takeover.
2023-05-12 English
Publication of Scheme Document
M&A Activity Classification · 99% confidence The document is an RNS announcement dated May 12, 2023, detailing a 'RECOMMENDED CASH ACQUISITION' of Medica Group PLC by Moonlight Bidco Limited. It specifically announces the 'Publication of Scheme Document' related to this acquisition, which is being implemented via a Scheme of Arrangement under Part 26 of the Companies Act 2006. This subject matter—a takeover bid or merger proposal—directly corresponds to the definition of M&A Activity (TAR). Although it announces the publication of a Scheme Document, the core content is the M&A transaction itself, not just a generic announcement about report publication (RPA) or a general regulatory filing (RNS). The key theme is the takeover/merger, making TAR the most specific fit.
2023-05-12 English
Form 8.3 - Medica Group plc
Regulatory Filings Classification · 95% confidence The document is explicitly titled "FORM 8.3 - Medica Group plc" and references "Rule 8.3 of the Takeover Code (the “Code”)". This form is a Public Opening Position Disclosure or Dealing Disclosure made by a person holding 1% or more interests in relevant securities during a takeover situation. This type of mandatory disclosure related to takeover activity and insider/significant shareholder dealings does not fit neatly into the standard financial reporting categories (10-K, IR, ER, etc.). While it involves director/insider activity, it is specifically mandated by the Takeover Code, making it a specialized regulatory filing concerning M&A activity. Given the options, it is a specific regulatory disclosure related to a potential takeover scenario. Since there is no specific code for 'Takeover Disclosure', and it is a mandatory filing related to corporate control/transactions, it falls best under the general 'Regulatory Filings' (RNS) category, as it is a required submission to the Takeover Panel and RNS, or potentially related to M&A (TAR). However, TAR is defined as 'Merger proposals or takeover bids' announcements, whereas this is a disclosure *during* the process. Given the highly specific nature of Form 8.3, which is a regulatory requirement during a takeover, RNS (Regulatory Filings) is the most appropriate general classification for mandatory, non-standard financial reports.
2023-05-11 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.